Treatment of neurometabolic epilepsies: Overview and recent advances

Itay Tokatly Latzer, Phillip L. Pearl*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The rarity and heterogeneity of neurometabolic diseases make it challenging to reach evidence-based principles for their specific treatments. Indeed, current treatments for many of these diseases remain symptomatic and supportive. However, an ongoing scientific and medical revolution has led to dramatic breakthroughs in molecular sciences and genetics, revealing precise pathophysiologic mechanisms. Accordingly, this has led to significant progress in the development of novel therapeutic approaches aimed at treating epilepsy resulting from these conditions, as well as their other manifestations. We overview recent notable treatment advancements, from vitamins, trace minerals, and diets to unique medications targeting the elemental pathophysiology at a molecular or cellular level, including enzyme replacement therapy, enzyme enhancing therapy, antisense oligonucleotide therapy, stem cell transplantation, and gene therapy.

Original languageEnglish
Article number109181
JournalEpilepsy and Behavior
StatePublished - May 2023


  • Inborn errors of metabolism
  • Metabolic
  • Progress
  • Therapy
  • Update


Dive into the research topics of 'Treatment of neurometabolic epilepsies: Overview and recent advances'. Together they form a unique fingerprint.

Cite this